[1]
“Structural insights into ?-glucuronidase inhibition to mitigate camptothecin chemoterapeutics side effects”, Int J of Pharm Chem, vol. 5, no. 11, pp. 375–380, Nov. 2015, doi: 10.7439/ijpc.v5i11.2742.